establishment of a regulated inflammatory response during wounding. Macrophage function is dictated by metabolism, which alters gene expression. The mitochondrial deacylase enzyme, Sirtuin 3 (SIRT3), was recently shown to suppress inflammatory signaling and decrease reactive oxygen species. Therefore, we investigated the role of SIRT3 in inflammation in peripheral wound macrophages.
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Methods: C57BL/6 mice maintained on a normal or high-fat diet for 12 weeks underwent 4-mm hind limb wounding, and macrophages (CD3-CD19-NK1.1-CD11b + cells) were isolated from wounds on days 1, 3, 5, and 7. SIRT3 expression was quantified by quantitative polymerase chain reaction. SIRT3 -/-mice and their littermate controls underwent 4-mm hind limb wounds, and wound closure was compared daily between the two groups for 1 week. Macrophages were isolated from mouse wounds on day 3 using magnetic bead sorting. Quantitative polymerase chain reaction was used to quantify expression of inflammatory cytokines. Protein data were obtained using flow cytometry.
Results: In this murine model of wound healing, CD11b + cells (macrophages) isolated from wounds demonstrated a significant threefold increase in SIRT3 gene expression during the intermediate stage (day 3-5) of wound healing. Additionally, when we examined wound macrophages from our diet-induced obese (DIO) model of diabetes, we found that they did not upregulate SIRT3. To directly examine the role of SIRT3 in wound healing, we wounded our SIRT3 -/-and littermate controls. We found that the SIRT3 -/-mice demonstrated significantly delayed wound healing compared to controls. Macrophages isolated from wounds of SIRT3 -/-mice on day 3 revealed significantly higher expression of inflammatory cytokines (tumor necrosis factor-a, interleukin 1b, nitric oxide synthase 2) compared with controls (P < .01).
Conclusions: SIRT3 is important in macrophages for normal wound healing and is decreased in macrophages from wounds of diabetic mice. These results suggest an important role for SIRT3 in regulating inflammation in wound healing.
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Critical Role of Endothelial Notch1 Signaling in Atherosclerosis
Methods: A genetically engineered mouse model, Notch1FLOX/FLOX/ VE-cadherin-CreERT2/ApoE -/-, which is a tamoxifen-inducible E -specific Notch1 gene knockout mouse on atherosclerosis-prone ApoE-deficient background, was established. Mice were fed a high-fat diet along with or without intraperitoneal tamoxifen treatment (2 mg/d for 5 consecutive days) starting from 4 weeks old and terminated on 16 weeks old. Aortas were harvested to study the effects of loss of Notch1 signaling in endothelial cells on the progression of aortic atherosclerosis. Deletion of Notch1 in endothelial cells was validated by immunostaining. Aortic plaque burden was evaluated by quantification of proportion of total aorta containing atherosclerosis detected by Oil-Red-O and hematoxylin-eosin staining using computer-aided image analysis. Blood was tested to measure lipid profile.
Results Objectives: The lack of a reliable animal hind limb gangrene model limits molecular investigation and preclinical treatment of critical limb ischemia. We sought to develop and characterize a mouse hind limb gangrene model and used it to assess the efficacy of novel gene therapy. We hypothesized that priming ischemic hind limb tissue with E-selectin/ adeno-associated virus (AAV) would enhance therapeutic angiogenesis and attenuate gangrene.
Methods: We tested two methods to induce hind limb gangrene. With the first method, FVB mice underwent femoral artery ligation (FAL) to achieve critical limb ischemia. With the second method, FVB mice underwent combined FAL and administration of NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, which further reduces hind limb perfusion. Prior to FAL and L-NAME use, gangrene-induced mice were intramuscularly administered E-selectin/AAV (treatment) or LacZ/AAV (control) to the hind limb. Gangrene was assessed using a standardized ischemia score ranging from 0 (no gangrene) to 11 (forefoot gangrene), recorded on postoperative days (PODs) 2, 7, 14. Hind limb reperfusion using laser Doppler imaging was quantified by mean perfusion of ligated/nonligated limb on same PODs. Live animal Dil perfusion plus laser scanning confocal microscopy was used to quantify limb neovascularization.
Results: Most FVB mice did not develop gangrene with the FAL-only method (n ¼ 2 of 8 [25% gangrene incidence]). Combined FAL and L-NAME method consistently induced hind limb gangrene (n ¼ 14 of 14 [100% gangrene incidence]). Laser Doppler imaging score on POD 7 for E-selectin/AAV (n ¼ 7) and LacZ/AAV (n ¼ 7) was 0.41 vs 0.27 (P ¼ .071) and on POD 14 was 0.54 vs 0.29 (P ¼ .017). Dil-perfused ligated hind limb in E-selectin/AAV and LacZ/AAV revealed significantly different mean neovascularization intensity score of 44 vs 21 (P ¼ .037). Dil-perfused nonligated limb in respective mice demonstrated mean intensity score of 50 vs 25 (P ¼ .006). Mean limb ischemia score on PODs 2, 7, and 14 for E-selectin/AAV and LacZ/AAV was 1.9, 2.9, and 3.7 vs 2.7, 3.9, and 5.3 (P ¼ .104).
Conclusions: We successfully developed a highly reliable mouse hind limb gangrene model, useful for translational studies. Using this model, our E-selectin-based novel gene therapy improved limb reperfusion and increased neovascuclarization in critical limb ischemia. This novel hind limb gangrene model can be utilized to further understand redox pathways contributing to gangrene, facilitating future translational studies.
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